(2R)-2-((1R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4-FLUOROPHENYL)-5,6-DIHYDRO-2H-1,4-OXAZINE
UNII 38EA8GN2BN
Substance Identification & Data
This profile provides standardized clinical and technical data for (2r)-2-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-5,6-dihydro-2h-1,4-oxazine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 38EA8GN2BN.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 380499-07-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H16F7NO2 KHOSCFXAHZBOCH-ADLMAVQZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2r)-2-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-5,6-dihydro-2h-1,4-oxazine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.